Sign in

CIK 0000926617

  • Non-accelerated filer
  • Smaller reporting company

Aspira Women's Health Inc.

Sign in to watch
Ticker
AWHL
Exchange
OTC
Industry
In Vitro & In Vivo Diagnostic Substances
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
330595156
Phone
+1 512-519-0400
Business address
12117 BEE CAVES ROAD BUILDING THREE, SUITE 100, AUSTIN, TX, 78738
Former names
VERMILLION, INC., CIPHERGEN BIOSYSTEMS INC
  1. 4 Derivatives Options or other derivatives
  2. 4 Derivatives Options or other derivatives
  3. 4 Grant or award Director acquired 26,250 shares (grant or award)
  4. 4 Grant or award Director acquired 35,324 shares (grant or award)
  5. 4 Grant or award Director acquired 21,389 shares (grant or award)
  6. 4 Grant or award Director acquired 25,602 shares (grant or award)
  7. 4 Grant or award Director acquired 22,685 shares (grant or award)
  8. 4 Open-market buy 10% owner bought 617,731 shares at $1.40 ($864,823)
  9. 4 Open-market buy 10% owner bought 1,947,052 shares at $1.40 ($2,725,873)
  10. 4 Open-market buy 10% owner bought 974,081 shares at $1.40 ($1,363,713)
  11. 4 Open-market buy Director bought 6,695 shares at $1.40 ($9,373)
  12. 4 Open-market buy Chief Operating Officer bought 6,695 shares at $1.40 ($9,373)
  13. 4 Open-market buy President & CEO bought 10,042 shares at $1.40 ($14,059)
  14. 4 Open-market buy Sr VP Finance & CAO bought 3,347 shares at $1.40 ($4,686)
  15. 4 Open-market buy Director bought 6,695 shares at $1.40 ($9,373)
  16. 4 Open-market buy Director bought 15,000 shares at $1.40 ($21,000)
  17. 4 Derivatives Options or other derivatives
  18. 4 Derivatives Options or other derivatives
  19. 4/A Grant or award Director acquired 33,182 shares (grant or award)
  20. 4 Derivatives Options or other derivatives

Page 14 of 28 · 551 filings